ciprofloxacin has been researched along with Mastitis in 8 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Mastitis: INFLAMMATION of the BREAST, or MAMMARY GLAND.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We conducted clinical studies on fleroxacin (FLRX), a new pyridone carboxylic acid derivative, for the treatment of periproctal abscess, secondary infections (due to wounds, burns or surgical operations), mastitis or areolitis and others with once daily dose of 200 mg or 300 mg." | 3.68 | [Clinical study on fleroxacin in surgical infections]. ( Ishikawa, M; Ishikawa, S; Kinoshita, H; Mashita, K; Mizuno, A; Morimoto, K; Sakai, K; Shinagawa, N; Suzuki, T; Yura, J, 1991) |
| " Plasma and milk elimination half-lives after P407-CMC dosing were 35." | 1.37 | Pharmacokinetic and milk penetration of a difloxacin long-acting poloxamer gel formulation with carboxy-methylcellulose in lactating goats. ( Cárceles, CM; Escudero, E; Fernández-Varón, E; Marín, P; Ramírez, MJ, 2011) |
| "Danofloxacin was the most active fluoroquinolone tested against Staph." | 1.36 | Short communication: Fluoroquinolone susceptibility of Staphylococcus aureus strains isolated from caprine clinical mastitis in southeast Spain. ( Cárceles, CM; Corrales, JC; Escudero, E; Fernández-Varón, E; Gómez-Martín, A; Marín, P; Martínez, I, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Ishaq, Z | 1 |
| Sikdar, O | 1 |
| Dobie, D | 1 |
| Sircar, T | 1 |
| Mukerji, A | 1 |
| Sulowski, C | 1 |
| Friedman, JN | 1 |
| Opavsky, MA | 1 |
| Escudero, E | 2 |
| Marín, P | 2 |
| Cárceles, CM | 2 |
| Ramírez, MJ | 1 |
| Fernández-Varón, E | 2 |
| Harji, DP | 1 |
| Rastall, S | 1 |
| Catchpole, C | 1 |
| Bright-Thomas, R | 1 |
| Thrush, S | 1 |
| Corrales, JC | 1 |
| Gómez-Martín, A | 1 |
| Martínez, I | 1 |
| Faro, J | 1 |
| Katz, A | 1 |
| Berens, P | 1 |
| Ross, PJ | 1 |
| Bodsworth, NJ | 1 |
| Price, R | 1 |
| Nelson, MJ | 1 |
| Yura, J | 1 |
| Shinagawa, N | 1 |
| Ishikawa, S | 1 |
| Mashita, K | 1 |
| Kinoshita, H | 1 |
| Morimoto, K | 1 |
| Sakai, K | 1 |
| Mizuno, A | 1 |
| Ishikawa, M | 1 |
| Suzuki, T | 1 |
1 review available for ciprofloxacin and Mastitis
| Article | Year |
|---|---|
Pseudomonal breast infection.
Topics: Abscess; Anti-Bacterial Agents; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Mastitis; | 2010 |
7 other studies available for ciprofloxacin and Mastitis
| Article | Year |
|---|---|
Topics: Abscess; Anti-Bacterial Agents; Breast; Ciprofloxacin; Diagnosis, Differential; Female; Humans; Mast | 2018 |
Salmonella Poona meningitis and mastitis causing neonatal meningitis.
Topics: Anti-Infective Agents; Ciprofloxacin; Female; Humans; Infant; Mastitis; Meningitis, Bacterial; Milk, | 2009 |
Pharmacokinetic and milk penetration of a difloxacin long-acting poloxamer gel formulation with carboxy-methylcellulose in lactating goats.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Chromatography, High Pressure Liquid; Ciprofloxaci | 2011 |
Short communication: Fluoroquinolone susceptibility of Staphylococcus aureus strains isolated from caprine clinical mastitis in southeast Spain.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Female; Fluoroquinolones; Goat Diseases; Goats; Masti | 2010 |
Premature termination of nursing secondary to Serratia marcescens breast pump contamination.
Topics: Adult; Anti-Bacterial Agents; Breast Feeding; Ciprofloxacin; Equipment Contamination; Female; Humans | 2011 |
A case of gonococcal mastitis in a male.
Topics: Adult; Ciprofloxacin; Floxacillin; Gonorrhea; Homosexuality; Humans; Male; Mastitis; Neisseria gonor | 1993 |
[Clinical study on fleroxacin in surgical infections].
Topics: Abscess; Administration, Oral; Adolescent; Adult; Aged; Bacteria; Ciprofloxacin; Drug Resistance, Mi | 1991 |